Steris (STE) EBITDA Margin Growth (1y) (2019 - 2026)
Steris (STE) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 146.00 |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 54.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 146.00 |
| Mar 31, 2026 | 535.00 |
| Dec 31, 2025 | 36.00 |
| Sep 30, 2025 | 167.00 |
| Jun 30, 2025 | 319.00 |
| Mar 31, 2025 | -93.00 |
| Dec 31, 2024 | 45.00 |
| Sep 30, 2024 | 106.00 |
| Jun 30, 2024 | -221.00 |
| Mar 31, 2024 | -4,288.00 |
| Dec 31, 2023 | 30.00 |
| Sep 30, 2023 | 4,356.00 |
| Jun 30, 2023 | 165.00 |
| Mar 31, 2023 | 4,651.00 |
| Dec 31, 2022 | 37.00 |
| Sep 30, 2022 | -3,782.00 |
| Jun 30, 2022 | 1,358.00 |
| Mar 31, 2022 | 1,192.00 |
| Dec 31, 2021 | -139.00 |
| Sep 30, 2021 | -895.00 |